IL-31、IL-33及其受体ST2在难治性鼻-鼻窦炎中的表达及意义

doi:10.6040/j.issn.1673-3770.0.2017.430

摘要/Abstract

摘要： 目的研究IL-31、IL-33及其受体ST2在难治性鼻-鼻窦炎(RRS)患者鼻黏膜组织中的表达,初步探讨其在RRS发病机制中的作用及意义。方法研究设立难治组、初治组及对照组。采用HE染色方法观察组织形态和检测嗜酸性粒细胞数(EOS);采用免疫组织化学法检测组织中IL-31、IL-33及ST2蛋白的相对含量;采用实时荧光定量PCR技术在mRNA水平检测IL-31、IL-33及ST2蛋白的表达;外周血检测血清总IgE的表达水平。结果 (1) 难治组、初治组的嗜酸性粒细胞数均高于对照组,难治组高于初治组;(2)免疫组织化学染色中,IL-31、IL-33在难治组、初治组及对照组均有表达,难治组、初治组表达量高于对照组,难治组高于初治组。ST2表达量难治组、初治组均高于对照组,但难治组与初治组之间差异无统计学意义;(3) 在mRNA表达水平上, IL-31、IL-33在难治组及初治组中的表达较对照组上调,难治组高于初治组;ST2表达量难治组、初治组均高于对照组,但难治组与初治组之间差异无统计学意义;(4)外周血总IgE值三组间差异无统计学意义。结论 IL-31、IL-33及其受体ST2可能在慢性鼻-鼻窦炎患者,尤其在难治性鼻-鼻窦炎患者发病机制中发挥重要作用;嗜酸性粒细胞浸润可能在难治性鼻-鼻窦炎的发展中有重要作用。

关键词: 白细胞介素31, 受体ST2, 嗜酸性粒细胞, 鼻窦炎, 难治性, 白细胞介素33

Abstract: Objective To study the expression of interleukinIL-31(IL-31), and interleukin-33(IL-33)and its receptor ST2, in the nasal mucosa of patients with refractory rhinosinusitis(RRS), and to investigate their role in the pathogenesis of RRS. Methods In this study, a refractory group, an initial treatment group, and a control group were established. The hematoxylin and eosin staining method was used to observe the morphology and detect the number of eosinophils(EOS)present in the mucosal tissues. The relative levels of IL-31, IL-33, and ST2 in the tissues were detected by immunohistological examination.Quantitative fluorescence real-time polymerase chain reaction was used to detect the mRNA levels of IL-31, IL-33, and ST2, and total serum immunoglobulin E(IgE)expression in the peripheral blood. Results (1)The number of EOS in the refractory group and initial treatment group were higher than that in the control group. Further, the number of EOS in the refractory group were higher than that in the initial group. (2) On immunohistological examination, the expression levels of IL-31 and IL-33 proteins in the refractory group and the initial treatment group were higher than those in the control group. Additionally, the expression levels of both IL-31 and IL-33were higher in the refractory group than in the initial treatment group. The expression of ST2 in the refractory group and the initial treatment group was higher than that in the control group, but there was no significant difference in the expression of ST2 between the refractory group and the initial treatment group. (3) At the level of mRNA expression, the levels of IL-31 and IL-33 in the refractory group and the initial treatment group were higher than those in the control group. Furthermore, the levels of IL-31 and IL-33 mRNA in the refractory group were higher than those in the initial treatment group. The ST2 mRNA levels in the refractory group and the initial treatment group were higher than that in the control group, but there was no significant difference between the refractory group and the initial treatmentgroup. (4) There was no significant difference between the three groups in the total IgE levels in the peripheral blood. Conclusion IL-31, and IL-33 along with its receptor ST2, may play an important role in the pathogenesis of chronic rhinosinusitis, especially in patients with RRS. Eosinophilic infiltration may also play an important role in the development of RRS.

Key words: Sinusitis, refractory, Receptor ST2, Eosinophils, Interleukin 33, Interleukin 31

中图分类号:

R765.4

张俐悦,刘金兰,姚东方,李杰恩. IL-31、IL-33及其受体ST2在难治性鼻-鼻窦炎中的表达及意义[J]. 山东大学耳鼻喉眼学报, 2018, 32(3): 37-41.

ZHANG Liyue, LIU Jinlan, YAO Dongfang, LI Jieen. The expression and significance of interleukin-31, and interleukin-33 and its receptor ST2, in refractory rhinosinusitis[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2018, 32(3): 37-41.

参考文献

[1] 王成硕,张罗. 慢性鼻窦炎的治疗策略[J]. 临床耳鼻咽喉头颈外科杂志,2016,30(14):1175-1178. WANG Chengshuo, ZHANG Luo. Management of chronic rhinosinusitis[J]. J Clin Otorhinolaryngol Head Neck Surg, 2016, 30(14):1175-1178.
[2] 韩德民. 难治性鼻及鼻窦炎[J]. 中国医学文摘(耳鼻咽喉科学),2010,25(2):59-62. [2017-09-15].
[3] 董革辉,魏培,黄俊琼,等. IL-31单克隆抗体的制备及ELISA检测方法的建立[J]. 中国免疫学杂志,2014,30(4):495-498. DONG Gehui, WEI Pei, HUANG Junqiong, et al. Preparation of monoclonal antibodies against IL-31 and development of sandwich ELISA for IL-31[J].Chin J Immunol, 2014, 30(4):495-498.
[4] Schmitz J, Owyang A, Oldham E, et al. IL-33,an interleukin-l-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines[J]. Immunity, 2005, 23(5):479-490.
[5] Dalm VA, de Wit H, Drexhage HA. Thymosin α 1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis[J]. Ann N Y Acad Sci, 2012, 1270:1-7.
[6] Desrosiers M. Refractory chronic rhinosinusitis: pathophysiology and management of chronic rhinosinusitis persisting after endoscopic sinus surgery[J]. Curr Allergy Asth Reports, 2004, 4(3):200-207.
[7] Fokkens W,Lund V,Mullol J,et al. European position paper on rhinosinusitis and nasal polyps 2007[J].Rhinol Suppl, 2007, 20: 1-136.
[8] Baumann R, Rabaszowski M, Stenin I, et al. The release of IL-31 and IL-13 after nasal allergen challenge and their relation to nasal symptoms[J]. Clin Transl Allergy, 2012, 2(1):13.
[9] 高雅倩,黄俊琼. 白介素31及其受体在过敏性呼吸道疾病中的作用[J]. 现代医药卫生,2015,31(19):2945-2947.
[10] 刘天聪, 吕昌龙, 曹志伟. IL-33及其受体ST2在伴鼻息肉的慢性鼻-鼻窦炎中的表达及意义[J]. 临床耳鼻咽喉头颈外科杂志, 2015,29(15):1350-1353. LIU Tiancong, LV Changlong, CAO Zhiwei. Expression and role of IL-33and its receptor ST2in eosinophilic and non-eosinophilic chronic rhinosinusitis with nasal polyps[J].J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(15):1350-1353.
[11] 郑霞, 邓丹立, 杨辉红. 嗜酸性粒细胞增多与临床[J]. 实用医技杂志, 2008, 15(5): 654-656.
[12] 王节,纪东,桂晓钟. 嗜酸性粒细胞在慢性鼻-鼻窦炎发病中表现的探讨[J]. 中国中西医结合耳鼻咽喉科杂志,2017,25(2):91-93. WANG Jie, JI Dong, GUI Xiaozhong. Study of eosinophils in the pathogenesis of chronic rhinosinusitis[J].Chin J Otorhinolaryngol Integrative Med, 2017, 25(2):91-93.

相关文章 15

[1]	冯思聪,于晓岚,娄丹. 基于囊泡组织Ki67、GM-CSF表达评估Messerklinger中鼻甲成形术对慢性鼻-鼻窦炎合并鼻息肉的效果[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 31-39.
[2]	翟雪纯,边欣,陈敬彩,邓家钰,叶子,杨萍丽. 慢性额窦炎患者焦虑抑郁特点及横断面研究[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 35-43.
[3]	李阳松,袁发洋,杨艳,张田,喻国冻. 基于Web of Science进行生物制剂治疗慢性鼻窦炎文献计量学分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 54-64.
[4]	杜康丽,郑振宇,徐战将,张宇,陈露,卢梦垚. 鼻中隔偏曲并发慢性鼻窦炎风险预测模型的构建与验证[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 78-86.
[5]	熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[6]	黄焕,华红利,邓玉琴,江承洋,王雨薇,杨星海. 儿童过敏性鼻炎、扁桃体腺样体肥大和鼻窦炎之间相关性及其对临床指导价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 34-41.
[7]	刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[8]	张家齐,袁野,洪陈,顾敏,程雷,陆美萍. 基于孟德尔随机化的肠道菌群与慢性鼻窦炎鼻息肉的因果关系及代谢物中介研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 49-60.
[9]	尹振乾,皇甫辉. 头颈部木村病1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 104-107.
[10]	张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[11]	张广玲,陈兴雪,武天义,孙占伟,王卫卫,李世超,王广科. Tespa1在慢性鼻窦炎伴鼻息肉中的表达及作用研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 35-42.
[12]	曹正勇,李小波. 慢性鼻-鼻窦炎合并哮喘术后短程局部使用糖皮质激素辅助治疗的安全性和有效性[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 43-50.
[13]	王文晴,张丹,朱梦迪,王路阳,杨培培,孙思思,张秋敏,周慧. 慢性鼻窦炎伴鼻息肉复发手术时临床及组织病理学特征变化[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 46-53.
[14]	王奥维,时文杰. CRSwNP中医证型与TFH细胞相关因子的相关性研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 54-60.
[15]	张婕,尼玛吉宗,徐小东,周菁,刘建敏,罗依蕤,杜进涛,巴罗. 藏红花素在嗜酸性慢性鼻窦炎伴鼻息肉中调控2型炎症反应的研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 61-67.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed